Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Operating Activities
Net income including noncontrolling interests	$ 2,266	$ 2,270
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization	457	457
ERISA litigation matter	65	0
Restructuring and termination benefits, net of cash	(15)	54
Stock-based compensation expense	127	108
Deferred income taxes	8	(98)
Cash effects of changes in:
Receivables	(180)	(184)
Inventories	9	(94)
Accounts payable and other accruals	30	327
Other non-current assets and liabilities	(22)	(2)
Net cash provided by (used in) operations	2,745	2,838
Investing Activities
Capital expenditures	(387)	(377)
Purchases of marketable securities and investments	(537)	(358)
Proceeds from sale of marketable securities and investments	508	260
Payment for acquisition, net of cash acquired	(293)	0
Other investing activities	(5)	21
Net cash provided by (used in) investing activities	(714)	(454)
Financing Activities
Short-term borrowing (repayment) less than 90 days, net	139	337
Principal payments of debt	(655)	(502)
Proceeds from issuance of debt	497	2
Dividends paid	(1,300)	(1,275)
Purchases of treasury shares	(804)	(1,284)
Proceeds from exercise of stock options	83	611
Other financing activities	145	1
Net cash provided by (used in) financing activities	(1,895)	(2,110)
Effect of exchange rate changes on Cash and cash equivalents	47	(6)
Net increase (decrease) in Cash and cash equivalents	183	268
Cash and cash equivalents at beginning of the period	1,096	966
Cash and cash equivalents at end of the period	1,279	1,234
Supplemental Cash Flow Information
Income taxes paid	712	762
Interest paid	$ 235	$ 267